<乌鸦传媒>ADC Offers Promising Results in Relapsed or Refractory Hodgkin Lymphoma Good response rate with camidanlumab tesirine, although a lot of patients experienced AEs Oct 02, 2022
<乌鸦传媒>Anti-BCMA-Based Regimen Impresses in Relapsed/Refractory Myeloma Belamaf plus lenalidomide-dexamethasone achieved encouraging responses Sep 30, 2022
<乌鸦传媒>Response-Based Ponatinib Dose Reduction a Win-Win in Chronic-Phase CML? Strategy applied in OPTIC trial may mitigate adverse events without sacrificing benefit Sep 29, 2022
<乌鸦传媒>Magrolimab-Azacitidine Shows Promise in Untreated High-Risk MDS About a third of patients, including those with TP53 mutations, achieved complete remission Sep 29, 2022
<乌鸦传媒>'Unparalleled Times' in Hematology, but Workforce Issues Persist "This is the most exciting time ever" to be a hematologist, says ASH President Jane Winter, MD Sep 26, 2022 video
<乌鸦传媒>What's on Tap at the Society of Hematologic Oncology's 10th Annual Meeting Emphasis on novel biological approaches in treating patients with hematologic malignancies Sep 26, 2022
<乌鸦传媒>How a Dedicated Bone Marrow Biopsy Clinic Eased Wait Times VA center in Cleveland got program up and running in about a month Sep 19, 2022
<乌鸦传媒>CAR-T Therapy Effective in Youngest Kids With ALL Analysis shows safety and outcomes equivalent to those reported in older children Sep 08, 2022
<乌鸦传媒>Jane Fonda's Non-Hodgkin Lymphoma The award-winning actress opened up about her latest health news Sep 06, 2022
<乌鸦传媒>Bispecific Antibody Active in Heavily Treated Multiple Myeloma Responses in 60% of patients who had received a median of five prior lines of therapy Aug 30, 2022
<乌鸦传媒>Low-Dose Hypomethylating Agents in Lower-Risk MDS Yield Promising Outcomes Overall response rates were 67% with decitabine, 48% with azacitidine Aug 22, 2022
<乌鸦传媒>PK Modulator Shows Promise in Thalassemia In small study, mitapivat increased hemoglobin in 80% of non-transfusion-dependent patients Aug 17, 2022
<乌鸦传媒>Mandy Moore's Immune Thrombocytopenic Purpura What does it mean for the pregnant pop singer/actress? Aug 10, 2022
<乌鸦传媒>Experts Warn of Physical, Mental Health Effects of Extreme Heat Children, people with sickle cell disease, and outdoor workers are particularly at risk Aug 05, 2022
<乌鸦传媒>Pneumococcal Vax Slashed Deadly Sickle-Cell Complication in Kids Cumulative ACS reduction of 41% since implementation of 13-valent vaccine, French study finds Aug 02, 2022
<乌鸦传媒>'Rogue' Online Pharmacies Are Dispensing Cancer Drugs Shady sites with little oversight are selling imatinib for much less than U.S. retail price Jul 29, 2022
<乌鸦传媒>Breast Implant-Related Lymphoma More Common Than Reported Contemporary data suggest at least a twofold higher case rate as compared with FDA estimates Jul 21, 2022
<乌鸦传媒>Second-Line CAR-T Impresses in Transplant-Ineligible Large B-Cell Lymphoma More than half of patients achieved complete responses with lisocabtagene maraleucel Jul 18, 2022
<乌鸦传媒>Blood Viscosity Enters the Equation in COVID Mortality Its association with death may be unrelated to inflammation Jul 18, 2022
<乌鸦传媒>Bone Marrow Biopsy Value Limited in Follicular Lymphoma Response Assessment Information useful in fewer than 1% of patients with untreated disease Jul 10, 2022
<乌鸦传媒>Zanubrutinib Wins in First-Line CLL for Older Patients The BTK inhibitor proves superior to bendamustine-rituximab in phase III trial Jul 08, 2022
<乌鸦传媒>FDA Warns of Increased Mortality Risk With Duvelisib Drug approved for adults with CLL/SLL Jul 01, 2022
<乌鸦传媒>Kidney Failure May Drive COVID Deaths in People With Sickle Cell Trait COVID-19 severity strongly linked with sickle cell anemia as well Jun 27, 2022
<乌鸦传媒>Brentuximab Vedotin Boosts Survival in Untreated Hodgkin Lymphoma ECHELON-1 analysis showed 41% mortality risk reduction versus standard treatment Jun 21, 2022
<乌鸦传媒>Studies Reinforce Prognostic Role for Circulating Tumor Cells in Myeloma At higher levels, different cutoffs show at least a doubling of PFS, OS hazard ratios Jun 13, 2022
<乌鸦传媒>FDA Panel Backs Gene Tx for Degenerative Brain Disorder in Kids Advisers unanimously recommend approval for pediatric ALD patients without HLA-matched donors Jun 10, 2022
<乌鸦传媒>Myeloma Trial Supports 'Personalized Approach' to Upfront Transplant DETERMINATION confirms benefit in triple-therapy setting, but suggests timing can be tailored Jun 06, 2022
<乌鸦传媒>Third-Line BTK Inhibitor Combo Doubles PFS in Follicular Lymphoma Significantly more responses, CRs with zanubrutinib-obinutuzumab versus anti-CD20 drug alone Jun 05, 2022
<乌鸦传媒>Brentuximab Vedotin-Chemo Boosts EFS in High-Risk Pediatric Hodgkin Lymphoma Combo regimen offers "a new standard for front-line therapy," researcher says Jun 04, 2022
<乌鸦传媒>Add-On Ibrutinib Boosts PFS in Untreated, Older Mantle-Cell Lymphoma Patients BTK inhibitor plus chemoimmunotherapy increased progression-free survival by over 2 years Jun 03, 2022
<乌鸦传媒>FDA Pulls Lymphoma Approvals for PI3K Inhibitor Umbralisib Worse overall survival observed despite improvements in progression-free survival Jun 01, 2022
<乌鸦传媒>Unprecedented PFS Improvement in Relapsed Multiple Myeloma Three-year median with addition of isatuximab to proteasome inhibitor backbone May 26, 2022
<乌鸦传媒>Elotuzumab Combination Disappoints in Newly Diagnosed Myeloma Study failed to replicate positive results seen in relapsed/refractory setting May 11, 2022
<乌鸦传媒>Corticosteroids Linked to Pain Events in Patients With Sickle Cell Disease Hospitalization risk for vaso-occlusive episodes four times higher after exposure May 02, 2022
<乌鸦传媒>Promising Data for Allo-Transplant After CAR T-Cell Failure in LBCL Durable responses with no unexpected or prolonged safety issues Apr 27, 2022
<乌鸦传媒>Eprenetapopt-Based Combo Impresses in TP53-Mutant AML/MDS 1-year relapse-free survival rate of 60% with maintenance therapy after transplant Apr 25, 2022
<乌鸦传媒>BTK Inhibitor Shows Potential in Immune Thrombocytopenia Across doses, 40% of heavily pretreated patients responded to oral rilzabrutinib Apr 13, 2022
<乌鸦传媒>Bispecific Antibody-NK Cell Complex Impresses in Early Hodgkin/NHL Trial Objective responses in 89% of patients with no CRS, neurotoxicity, or graft-versus-host disease Apr 11, 2022
<乌鸦传媒>9/11 Responders More Likely to Carry Genetic Mutations Tied to Cancer Clonal hematopoiesis seen in 10% of firefighters, medical personnel on the scene after WTC attack Mar 07, 2022
<乌鸦传媒>Cancer May Heighten Odds of Guillain-Barre Syndrome Link strongest with hematologic malignancies as well as prostate, breast, and respiratory cancers Mar 03, 2022
